Resolvyx Pharmaceuticals, Inc   Report issue

For profit Phase 1 Phase 2
Founded: Cambridge MA United States (2001)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2008
NCT00799552
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

rx-10045 (1 trial)

Drugs in Phase 1 Trials (1)

rx-10001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dry Eye Syndromes (Phase 2)

Keratoconjunctivitis Sicca (Phase 2)

Signs and Symptoms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2